Advertisement
Screener

XTL BIOPHARMACEUTICALS LTD. (XTLB) Form 6-K: Report of foreign private issuer, 2025

XTL BIOPHARMACEUTICALS LTD. Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2025-12-30: Form 6-K; Period of report 2025-12-30; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea0271177-6k_xtlbio.htm.
  • 2025-12-29: Form 6-K; Period of report 2025-12-29; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea0271127-6k_xtlbio.htm.
  • 2025-12-12: Form 6-K; Period of report 2025-12-12; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea0269577-6k_xtlbio.htm.
  • 2025-12-05: Form 6-K; Period of report 2025-12-05; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea0268692-6k_xtlbio.htm.
FiledFormPeriod of reportDescriptionDocument
2025-12-306-K2025-12-30REPORT OF FOREIGN PRIVATE ISSUERea0271177-6k_xtlbio.htm
2025-12-296-K2025-12-29REPORT OF FOREIGN PRIVATE ISSUERea0271127-6k_xtlbio.htm
2025-12-126-K2025-12-12REPORT OF FOREIGN PRIVATE ISSUERea0269577-6k_xtlbio.htm
2025-12-056-K2025-12-05REPORT OF FOREIGN PRIVATE ISSUERea0268692-6k_xtlbio.htm
2025-10-236-K2025-10-22REPORT OF FOREIGN PRIVATE ISSUERea0262263-6k_xtlbio.htm
2025-07-286-K2025-07-28REPORT OF FOREIGN PRIVATE ISSUERea0250440-6k_xtlbiopharma.htm
2025-07-216-K2025-07-21REPORT OF FOREIGN PRIVATE ISSUERea0249696-6k_xtlbiopharma.htm
2025-06-186-K/A2025-06-18AMENDMENT NO. 1 TO FORM 6-Kea0246178-6ka1_xtlbio.htm
2025-06-136-K2025-06-13REPORT OF FOREIGN PRIVATE ISSUERea0245736-6k_xtlbio.htm
2025-04-076-K2025-04-07REPORT OF FOREIGN PRIVATE ISSUERea0237311-6k_xtlbio.htm
2025-03-046-K2025-03-04REPORT OF FOREIGN PRIVATE ISSUERea0232850-6k_xtlbio.htm
2025-02-036-K2025-02-03REPORT OF FOREIGN PRIVATE ISSUERea0229687-6k_xtlbio.htm